RN214_HUMAN - dbPTM
RN214_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RN214_HUMAN
UniProt AC Q8ND24
Protein Name RING finger protein 214
Gene Name RNF214
Organism Homo sapiens (Human).
Sequence Length 703
Subcellular Localization
Protein Description
Protein Sequence MAASEVAGVVANAPSPPESSSLCASKSDEGLPDGLSTKDSAQKQKNSPLLSVSSQTITKENNRNVHLEHSEQNPGSSAGDTSAAHQVVLGENLIATALCLSGSGSQSDLKDVASTAGEEGDTSLRESLHPVTRSLKAGCHTKQLASRNCSEEKSPQTSILKEGNRDTSLDFRPVVSPANGVEGVRVDQDDDQDSSSLKLSQNIAVQTDFKTADSEVNTDQDIEKNLDKMMTERTLLKERYQEVLDKQRQVENQLQVQLKQLQQRREEEMKNHQEILKAIQDVTIKREETKKKIEKEKKEFLQKEQDLKAEIEKLCEKGRREVWEMELDRLKNQDGEINRNIMEETERAWKAEILSLESRKELLVLKLEEAEKEAELHLTYLKSTPPTLETVRSKQEWETRLNGVRIMKKNVRDQFNSHIQLVRNGAKLSSLPQIPTPTLPPPPSETDFMLQVFQPSPSLAPRMPFSIGQVTMPMVMPSADPRSLSFPILNPALSQPSQPSSPLPGSHGRNSPGLGSLVSPHGPHMPPAASIPPPPGLGGVKASAETPRPQPVDKLEKILEKLLTRFPQCNKAQMTNILQQIKTARTTMAGLTMEELIQLVAARLAEHERVAASTQPLGRIRALFPAPLAQISTPMFLPSAQVSYPGRSSHAPATCKLCLMCQKLVQPSELHPMACTHVLHKECIKFWAQTNTNDTCPFCPTLK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAASEVAGV
------CCHHHHCCE
21.5019413330
4Phosphorylation----MAASEVAGVVA
----CCHHHHCCEEC
24.0620068231
15PhosphorylationGVVANAPSPPESSSL
CEECCCCCCCCCCCC
51.1525159151
19PhosphorylationNAPSPPESSSLCASK
CCCCCCCCCCCCCCC
30.8823401153
20PhosphorylationAPSPPESSSLCASKS
CCCCCCCCCCCCCCC
26.1824300666
21PhosphorylationPSPPESSSLCASKSD
CCCCCCCCCCCCCCC
36.4324300666
25PhosphorylationESSSLCASKSDEGLP
CCCCCCCCCCCCCCC
31.5319413330
27PhosphorylationSSLCASKSDEGLPDG
CCCCCCCCCCCCCCC
38.1022777824
36PhosphorylationEGLPDGLSTKDSAQK
CCCCCCCCCHHHHHH
38.6527251275
37PhosphorylationGLPDGLSTKDSAQKQ
CCCCCCCCHHHHHHH
43.8629396449
40 (in isoform 2)Phosphorylation-33.8725159151
40PhosphorylationDGLSTKDSAQKQKNS
CCCCCHHHHHHHCCC
33.8728985074
47 (in isoform 2)Phosphorylation-24.7825159151
47PhosphorylationSAQKQKNSPLLSVSS
HHHHHCCCCCEEECC
24.7830266825
51PhosphorylationQKNSPLLSVSSQTIT
HCCCCCEEECCEEEE
27.8630266825
53PhosphorylationNSPLLSVSSQTITKE
CCCCEEECCEEEECC
17.2223911959
54PhosphorylationSPLLSVSSQTITKEN
CCCEEECCEEEECCC
29.2325159151
56PhosphorylationLLSVSSQTITKENNR
CEEECCEEEECCCCC
32.3425159151
58PhosphorylationSVSSQTITKENNRNV
EECCEEEECCCCCCE
35.3823403867
91UbiquitinationAHQVVLGENLIATAL
HHHHHHCCCHHHHHH
44.71-
101PhosphorylationIATALCLSGSGSQSD
HHHHHHHHCCCCHHH
29.8927251275
103PhosphorylationTALCLSGSGSQSDLK
HHHHHHCCCCHHHHH
31.7128348404
104UbiquitinationALCLSGSGSQSDLKD
HHHHHCCCCHHHHHH
32.9821890473
105PhosphorylationLCLSGSGSQSDLKDV
HHHHCCCCHHHHHHH
28.3626657352
107PhosphorylationLSGSGSQSDLKDVAS
HHCCCCHHHHHHHHH
46.7529460479
122PhosphorylationTAGEEGDTSLRESLH
HCCCCCCCHHHHHCC
40.2828555341
123PhosphorylationAGEEGDTSLRESLHP
CCCCCCCHHHHHCCH
30.1225159151
127PhosphorylationGDTSLRESLHPVTRS
CCCHHHHHCCHHHHH
26.0828555341
134PhosphorylationSLHPVTRSLKAGCHT
HCCHHHHHHHHCCCH
25.51-
142AcetylationLKAGCHTKQLASRNC
HHHCCCHHHHHHCCC
21.4625953088
143UbiquitinationKAGCHTKQLASRNCS
HHCCCHHHHHHCCCC
43.3421890473
146PhosphorylationCHTKQLASRNCSEEK
CCHHHHHHCCCCCCC
32.3922985185
150PhosphorylationQLASRNCSEEKSPQT
HHHHCCCCCCCCCCC
52.9526657352
154PhosphorylationRNCSEEKSPQTSILK
CCCCCCCCCCCCCCC
26.0625159151
157PhosphorylationSEEKSPQTSILKEGN
CCCCCCCCCCCCCCC
22.5628985074
158PhosphorylationEEKSPQTSILKEGNR
CCCCCCCCCCCCCCC
22.2226552605
161UbiquitinationSPQTSILKEGNRDTS
CCCCCCCCCCCCCCC
63.00-
167PhosphorylationLKEGNRDTSLDFRPV
CCCCCCCCCCCCEEC
28.1430266825
168PhosphorylationKEGNRDTSLDFRPVV
CCCCCCCCCCCEECC
30.1730266825
176PhosphorylationLDFRPVVSPANGVEG
CCCEECCCCCCCCCC
20.6630266825
176UbiquitinationLDFRPVVSPANGVEG
CCCEECCCCCCCCCC
20.66-
194PhosphorylationDQDDDQDSSSLKLSQ
CCCCCCCCCCCCHHH
19.0520873877
195UbiquitinationQDDDQDSSSLKLSQN
CCCCCCCCCCCHHHC
48.24-
195PhosphorylationQDDDQDSSSLKLSQN
CCCCCCCCCCCHHHC
48.2420873877
196PhosphorylationDDDQDSSSLKLSQNI
CCCCCCCCCCHHHCE
33.2120873877
200PhosphorylationDSSSLKLSQNIAVQT
CCCCCCHHHCEEEEC
21.4219664994
224UbiquitinationNTDQDIEKNLDKMMT
CCHHHHHHHHHHHHH
64.24-
228UbiquitinationDIEKNLDKMMTERTL
HHHHHHHHHHHHHHH
33.46-
231PhosphorylationKNLDKMMTERTLLKE
HHHHHHHHHHHHHHH
20.8628842319
240PhosphorylationRTLLKERYQEVLDKQ
HHHHHHHHHHHHHHH
15.3228796482
246UbiquitinationRYQEVLDKQRQVENQ
HHHHHHHHHHHHHHH
43.13-
259UbiquitinationNQLQVQLKQLQQRRE
HHHHHHHHHHHHHHH
31.6921890473
259UbiquitinationNQLQVQLKQLQQRRE
HHHHHHHHHHHHHHH
31.6921890473
277UbiquitinationKNHQEILKAIQDVTI
HHHHHHHHHHHHHHC
49.45-
285UbiquitinationAIQDVTIKREETKKK
HHHHHHCCHHHHHHH
44.37-
298UbiquitinationKKIEKEKKEFLQKEQ
HHHHHHHHHHHHHHH
55.5821890473
298UbiquitinationKKIEKEKKEFLQKEQ
HHHHHHHHHHHHHHH
55.5821890473
303UbiquitinationEKKEFLQKEQDLKAE
HHHHHHHHHHHHHHH
60.53-
308UbiquitinationLQKEQDLKAEIEKLC
HHHHHHHHHHHHHHH
52.87-
331UbiquitinationEMELDRLKNQDGEIN
HHHHHHHHCCCCCCC
54.15-
350UbiquitinationEETERAWKAEILSLE
HHHHHHHHHHHHCHH
34.85-
355PhosphorylationAWKAEILSLESRKEL
HHHHHHHCHHHHHHE
35.4321406692
358PhosphorylationAEILSLESRKELLVL
HHHHCHHHHHHEEEE
54.6821406692
359MethylationEILSLESRKELLVLK
HHHCHHHHHHEEEEE
27.39115491417
360UbiquitinationILSLESRKELLVLKL
HHCHHHHHHEEEEEH
63.09-
382UbiquitinationELHLTYLKSTPPTLE
HHHHEECCCCCCCHH
41.70-
383PhosphorylationLHLTYLKSTPPTLET
HHHEECCCCCCCHHH
43.4822199227
384PhosphorylationHLTYLKSTPPTLETV
HHEECCCCCCCHHHH
31.5322199227
399PhosphorylationRSKQEWETRLNGVRI
HCHHHHHHHHHCEEE
41.3420068231
458PhosphorylationQVFQPSPSLAPRMPF
EECCCCCCCCCCCCC
41.3124719451
462MethylationPSPSLAPRMPFSIGQ
CCCCCCCCCCCEECE
39.54115387729
483PhosphorylationMPSADPRSLSFPILN
CCCCCCCCCCCCCCC
33.4823403867
485PhosphorylationSADPRSLSFPILNPA
CCCCCCCCCCCCCHH
30.1726074081
494PhosphorylationPILNPALSQPSQPSS
CCCCHHHCCCCCCCC
42.0028450419
497PhosphorylationNPALSQPSQPSSPLP
CHHHCCCCCCCCCCC
47.2726055452
500PhosphorylationLSQPSQPSSPLPGSH
HCCCCCCCCCCCCCC
36.6323401153
501PhosphorylationSQPSQPSSPLPGSHG
CCCCCCCCCCCCCCC
36.8225159151
506PhosphorylationPSSPLPGSHGRNSPG
CCCCCCCCCCCCCCC
22.3421712546
511PhosphorylationPGSHGRNSPGLGSLV
CCCCCCCCCCCCCCC
20.9829255136
516PhosphorylationRNSPGLGSLVSPHGP
CCCCCCCCCCCCCCC
30.5529255136
519PhosphorylationPGLGSLVSPHGPHMP
CCCCCCCCCCCCCCC
19.2429255136
530PhosphorylationPHMPPAASIPPPPGL
CCCCCCHHCCCCCCC
37.4228348404
546PhosphorylationGVKASAETPRPQPVD
CCCCCCCCCCCCCHH
25.0625159151
554UbiquitinationPRPQPVDKLEKILEK
CCCCCHHHHHHHHHH
59.80-
561AcetylationKLEKILEKLLTRFPQ
HHHHHHHHHHHHCCC
45.4025953088
564PhosphorylationKILEKLLTRFPQCNK
HHHHHHHHHCCCCCH
40.47-
619MethylationASTQPLGRIRALFPA
HCCCCCHHHHHHCCC
23.93115491421
621DimethylationTQPLGRIRALFPAPL
CCCCHHHHHHCCCCH
24.71-
621MethylationTQPLGRIRALFPAPL
CCCCHHHHHHCCCCH
24.7118601127
633PhosphorylationAPLAQISTPMFLPSA
CCHHHCCCCEECCCC
22.02-
643PhosphorylationFLPSAQVSYPGRSSH
ECCCCCCCCCCCCCC
17.33-
644PhosphorylationLPSAQVSYPGRSSHA
CCCCCCCCCCCCCCC
15.73-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RN214_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RN214_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RN214_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of RN214_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RN214_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-25 AND SER-53, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-25 AND SER-53, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-497; SER-500 ANDSER-511, AND MASS SPECTROMETRY.

TOP